STEPHEN TAYLOR: Open Payments
NPI 1447354907 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,521 in 21 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $425 · 2025 $5,521
Consulting: $3,560Travel & lodging: $1,449Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| Emergent BioSolutions Inc. | 7 | $5,110 |
| Indivior Inc. | 2 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $91 |
| Braeburn Inc. | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Alkermes, Inc. | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: CAPLYTA, BRIXADI, TRINTELLIX, Auvelity, VIVITROL, SUBLOCADE, SPRAVATO.
Industry payments across AL — which companies pay providers there.
